0001246360-14-001551.txt : 20140303
0001246360-14-001551.hdr.sgml : 20140303
20140303172812
ACCESSION NUMBER: 0001246360-14-001551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140228
FILED AS OF DATE: 20140303
DATE AS OF CHANGE: 20140303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDTRONIC INC
CENTRAL INDEX KEY: 0000064670
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 410793183
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0429
BUSINESS ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
STREET 2: MS LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
BUSINESS PHONE: 7635144000
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AYOTTE NEIL P
CENTRAL INDEX KEY: 0001582015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07707
FILM NUMBER: 14661651
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
STREET 2: MSLC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-02-28
false
0000064670
MEDTRONIC INC
MDT
0001582015
AYOTTE NEIL P
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS
MN
55432
false
true
false
false
VP Interim Gen Counsel CorpSec
Common Stock
875.72
I
ESOP
Common Stock
2014-02-28
4
M
false
3500
50
A
14398.448
D
Common Stock
2014-02-28
4
M
false
3500
59.6355
D
10898.448
D
Common Stock
2014-02-28
4
S
false
116
59.544
D
10782.448
D
Employee Stock Option (right to buy)
50
2014-02-28
4
M
false
3500
0
D
2004-10-21
2014-10-21
Common Stock
3500
0
D
This balance increased by 48.183 shares due to exempt transactions such as dividend reinvestment.
The price reported in Column 4, footnote 2, is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.631 to $59.645, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this form.
Rhonda L. Ingalsbe, Attorney-in-fact
2014-03-03